Lanean...
Bedaquiline for the Treatment of Multidrug-resistant Tuberculosis in the United States
BACKGROUND: In 2012, the Food and Drug Administration approved use of bedaquiline fumarate as part of combination therapy for multidrug-resistant tuberculosis (MDR TB). We describe treatment outcomes, safety, and tolerability of bedaquiline in our case series. METHODS: Data on patients started on be...
Gorde:
| Argitaratua izan da: | Clin Infect Dis |
|---|---|
| Egile Nagusiak: | , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7350275/ https://ncbi.nlm.nih.gov/pubmed/31556947 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz914 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|